BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24504078)

  • 1. World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013.
    Umar M; Khan AG; Abbas Z; Arora S; Asifabbas N; Elewaut A; Esmat G; Foster G; Fried M; Goh KL; Hamama TB; Imawari M; Isakov V; Krabshuis J; LaBrecque D; Lemair A; Malfertheiner P; Ryder S; Schiedermaier P; Stimac D; Tandon R; Villamil F; Zapata R; Ferenci P;
    J Clin Gastroenterol; 2014 Mar; 48(3):204-17. PubMed ID: 24504078
    [No Abstract]   [Full Text] [Related]  

  • 2. New hepatitis C guidelines for the Asia-Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    Farrell GC
    J Gastroenterol Hepatol; 2007 May; 22(5):607-10. PubMed ID: 17444844
    [No Abstract]   [Full Text] [Related]  

  • 3. Latin American Association for the Study of the Liver Practice Guidelines. Diagnosis, management, and treatment of hepatitis C.
    Latin American Association for the Study of the Liver
    Ann Hepatol; 2010; 9 Suppl():8-26. PubMed ID: 20713990
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of new hepatitis C treatments in different regions of the world.
    Wei L; Lok AS
    Gastroenterology; 2014 May; 146(5):1145-50.e1-4. PubMed ID: 24662488
    [No Abstract]   [Full Text] [Related]  

  • 5. The epidemiology and control of hepatitis C infection.
    Gungabissoon U
    Nurs Times; 2003 Aug 5-11; 99(31):24-5. PubMed ID: 13677115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection management in 2012.
    Van Gulick JJ; Lamers MH; Drenth JP
    Panminerva Med; 2012 Mar; 54(1):1-9. PubMed ID: 22278112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Boceprevir-benefit assessment by the Institute for Quality and Efficiency in Health Care (IQWiG) in accordance with § 35a SGB V (dosage evaluation)].
    Dignass A; Faiss S; Galle P; Layer P; Lerch M; Malfertheiner P; Wehrmann T; Zeuzem S;
    Z Gastroenterol; 2012 Jan; 50(1):20-1. PubMed ID: 22222793
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV and STD prevention update. CDC updates recommendations for hepatitis C.
    Makulowich GS
    AIDS Patient Care STDS; 1999 Jan; 13(1):65-7. PubMed ID: 11362096
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute hepatitis C treatment.
    Lerias de Almeida PR
    Ann Hepatol; 2010; 9 Suppl():107-11. PubMed ID: 20714006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
    Lucidarme D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C.
    Colletta C; Smirne C; Marini C; Pirisi M
    J Clin Gastroenterol; 2008 Feb; 42(2):219-20. PubMed ID: 18209600
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatitis C--the misdiagnosed epidemic. Chances for healing are available--use them!].
    Westphal K
    MMW Fortschr Med; 2006 Apr; 148(16):4-6, 8. PubMed ID: 16688938
    [No Abstract]   [Full Text] [Related]  

  • 13. [The era of management of hepatitis c patients].
    Moradpour D; Hadengue A
    Rev Med Suisse; 2011 Sep; 7(307):1667-8. PubMed ID: 21987873
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C: treatment challenges.
    Copley L
    Prof Nurse; 2003 Nov; 19(3):133-4. PubMed ID: 14639900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    ; McCaughan GW; Omata M; Amarapurkar D; Bowden S; Chow WC; Chutaputti A; Dore G; Gane E; Guan R; Hamid SS; Hardikar W; Hui CK; Jafri W; Jia JD; Lai MY; Wei L; Leung N; Piratvisuth T; Sarin S; Sollano J; Tateishi R
    J Gastroenterol Hepatol; 2007 May; 22(5):615-33. PubMed ID: 17444847
    [No Abstract]   [Full Text] [Related]  

  • 16. [Guidelines for the prevention and treatment of hepatitis C (2019 version)].
    ;
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):962-979. PubMed ID: 31941258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus therapies.
    Smith RE
    Nat Rev Drug Discov; 2006 Sep; 5(9):715-6. PubMed ID: 17001802
    [No Abstract]   [Full Text] [Related]  

  • 18. Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus.
    Burra P; De Martin E
    Transplant Proc; 2011; 43(6):2455-6. PubMed ID: 21839292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and outcome of hepatitis C relapse in transplant recipients.
    Angelico M
    Transplant Proc; 2011; 43(6):2457-8. PubMed ID: 21839293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of HCV-infected pregnant women.
    Valladares G; Chacaltana A; Sjogren MH
    Ann Hepatol; 2010; 9 Suppl():92-7. PubMed ID: 20714003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.